{"name":"Tocagen Inc.","slug":"tocagen-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxObGF5NlZKUE9NdHpzUDFQWm5jc0o1TmU5NzJzbVlkM2dIOVdxSTkwTGoyS1VHX3RSSHNlNGNsX2ZEMkhqRC1jVGtWMHdmNE4ySExPTi16RndzcHpxUUo4bEM0Q2NIeGlCNWk3Y29rMTJDNzd6TFNXSzV6Tk5fcVF5OTN0U19ldmhNT09YUVRFQmszY3F2Sm14c3hzdm53dlNhTWhCQkJOcjdfMVhHb3VTZEVvc09tb2M3TGxwVjBpcWpnWVhaZHYzdzBSSkx6X2xoaEJMSE1wZTJKTXluYm10cGp3R25kU1NaZk1PNldtZHk?oc=5","date":"2021-02-25","type":"deal","source":"PR Newswire","summary":"Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement - PR Newswire","headline":"Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNWEtyNmdSRl9VRy1qNG5sMkduVks5X3dmTFBIN2x1dkVWU18wcFN6eEpKSzZjeXlhY0MyelQwclJrNHA2OEQ0NGNEUU9vQU40RnJFd0NhWTZpYTZQVDJPVElCYlZLNFJaOGNCMTFJaUx6azlIMFZLdkdEd0paNldiWDQtUzFtYmw1Y0p2aTZfS3NUU2RZOW1aMG5mT1FoWjkxcFdSZGpoeDZyVndweFNoS0lxS0Y5c25PZ281bHlfTlE?oc=5","date":"2020-02-27","type":"earnings","source":"PR Newswire","summary":"Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results - PR Newswire","headline":"Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNMFRJQjNLUzdnTjVpOUdhT2hIbDZUWjlDbW8wQUFYZmFETGlFWTNzZ1Jab3NmdG0xbHYxSjQ5aldhaDhHeUdiUDJrejJqMUtuSUhFT0ZBUnU2a21nYmN4aE9aT043c1N1NERqM2E4S0hsY25zZThlcUpRSDQyRVN4al9xTTZsQW9yY2pyMUJyUEp4Vi1Q?oc=5","date":"2020-02-20","type":"deal","source":"BioPharma Dive","summary":"Tocagen restructuring leads to reverse merger with Forte - BioPharma Dive","headline":"Tocagen restructuring leads to reverse merger with Forte","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5kWGxxMHpTNE15bFZlSWtCS1dHMEhqeWFPdnItb2lMbnJIVTFlWHJZaGpsbjlVUW5ENFJ4YWw5cnRYZ3A2bElaZUdjMTBvNTl2d1VxUzdkZ01VYWhSNGNBVDBoN0tDMXV4ZWNxaURidldFdHFSX1lHeFVn?oc=5","date":"2020-02-19","type":"deal","source":"BioSpace","summary":"Tocagen and Forte Biosciences Announce Merger - BioSpace","headline":"Tocagen and Forte Biosciences Announce Merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPQjNQUmtzMVNYZ0xDLXVTbEFqREFOVlhEMjFscm5YSFRKQzg0T1FxQ0c3akhPdHh5OTZ5UkFWdHZicWh2S2l4S2h3RmZIWGVnajMyTUUyRXNIdnd1UUZaQVBPRWlYWEs0SGVmZkRDX1ZycnlRMzRGMGhIelIxYzVWdkV6RDdyejZDcXVuWEJzZTlHcWxybWFnY2ZIdTVmQmxiUnc?oc=5","date":"2019-10-03","type":"pipeline","source":"BioPharma Dive","summary":"Tocagen to lay off two-thirds of company after R&D setback - BioPharma Dive","headline":"Tocagen to lay off two-thirds of company after R&D setback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPSk1mT3pqdlJIMktWS3RvaEhjZl9rV3JrSVV4NHYzdDhQRE9iZ1FTb0VYUWptUmdGU01TWWJib0tBc1RyTHgtZ0ZCUUp3T0otNXR2YlZDMDlUajBubjlZTTNxeXVXU05ZZGNaekloSGJBc2hPTllUUDlXWl9sMGVXWlFVZnE2OHpGUHpxdExvLVZyOWVaWmR5SHlPdGQzRzQ?oc=5","date":"2019-09-12","type":"trial","source":"BioSpace","summary":"Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer - BioSpace","headline":"Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNNWVuSnVBcjVXMTdxYW1vQ2dlQm4ydGVoVjU1QXVsLXptRDhpN0pYdHFDd2dKazI1OEx5SklZdjlEb3dkYzNJMnFZRXJfWHNWaklIQnVzRGdOYWRXZnpJVFl1LTZ5OE1LTFRTV19XUGFIcjdHZTI1Ym5rNHIwWnYwQ3FLdw?oc=5","date":"2017-12-18","type":"pipeline","source":"BioPharma Dive","summary":"Biotech IPOs show no signs of slowing down in 2018 - BioPharma Dive","headline":"Biotech IPOs show no signs of slowing down in 2018","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}